CN117126119A - Preparation method of (benzo) thiazole amide-containing compound - Google Patents
Preparation method of (benzo) thiazole amide-containing compound Download PDFInfo
- Publication number
- CN117126119A CN117126119A CN202311086798.1A CN202311086798A CN117126119A CN 117126119 A CN117126119 A CN 117126119A CN 202311086798 A CN202311086798 A CN 202311086798A CN 117126119 A CN117126119 A CN 117126119A
- Authority
- CN
- China
- Prior art keywords
- chloride
- amino
- compound
- preparation
- ethyl acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 (benzo) thiazole amide Chemical class 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 150000001875 compounds Chemical class 0.000 title claims description 8
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 claims abstract description 40
- 239000002904 solvent Substances 0.000 claims abstract description 35
- 150000001263 acyl chlorides Chemical class 0.000 claims abstract description 14
- 229940125904 compound 1 Drugs 0.000 claims abstract description 14
- 229940125782 compound 2 Drugs 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000003513 alkali Substances 0.000 claims abstract description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 147
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 58
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 27
- 238000002156 mixing Methods 0.000 claims description 26
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 22
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 claims description 19
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical group ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 claims description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 14
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- 239000002585 base Substances 0.000 claims description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 7
- CXJOONIFSVSFAD-UHFFFAOYSA-N 2-(4-methoxyphenyl)acetyl chloride Chemical compound COC1=CC=C(CC(Cl)=O)C=C1 CXJOONIFSVSFAD-UHFFFAOYSA-N 0.000 claims description 6
- GRIATXVEXOFBGO-UHFFFAOYSA-N 4-methyl-1,3-benzothiazol-2-amine Chemical compound CC1=CC=CC2=C1N=C(N)S2 GRIATXVEXOFBGO-UHFFFAOYSA-N 0.000 claims description 6
- GUABFMPMKJGSBQ-UHFFFAOYSA-N 5-methyl-1,3-thiazol-2-amine Chemical compound CC1=CN=C(N)S1 GUABFMPMKJGSBQ-UHFFFAOYSA-N 0.000 claims description 6
- KZHGPDSVHSDCMX-UHFFFAOYSA-N 6-methoxy-1,3-benzothiazol-2-amine Chemical compound COC1=CC=C2N=C(N)SC2=C1 KZHGPDSVHSDCMX-UHFFFAOYSA-N 0.000 claims description 6
- DZWTXWPRWRLHIL-UHFFFAOYSA-N 6-methyl-1,3-benzothiazol-2-amine Chemical compound CC1=CC=C2N=C(N)SC2=C1 DZWTXWPRWRLHIL-UHFFFAOYSA-N 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 claims description 6
- UHGULLIUJBCTEF-UHFFFAOYSA-N 2-aminobenzothiazole Chemical compound C1=CC=C2SC(N)=NC2=C1 UHGULLIUJBCTEF-UHFFFAOYSA-N 0.000 claims description 5
- OFTKFKYVSBNYEC-UHFFFAOYSA-N 2-furoyl chloride Chemical compound ClC(=O)C1=CC=CO1 OFTKFKYVSBNYEC-UHFFFAOYSA-N 0.000 claims description 5
- OUQMXTJYCAJLGO-UHFFFAOYSA-N 4-methyl-1,3-thiazol-2-amine Chemical compound CC1=CSC(N)=N1 OUQMXTJYCAJLGO-UHFFFAOYSA-N 0.000 claims description 5
- VMNXKIDUTPOHPO-UHFFFAOYSA-N 6-chloro-1,3-benzothiazol-2-amine Chemical compound C1=C(Cl)C=C2SC(N)=NC2=C1 VMNXKIDUTPOHPO-UHFFFAOYSA-N 0.000 claims description 5
- MIHADVKEHAFNPG-UHFFFAOYSA-N 2-Amino-5-nitrothiazole Chemical compound NC1=NC=C([N+]([O-])=O)S1 MIHADVKEHAFNPG-UHFFFAOYSA-N 0.000 claims description 4
- 229940018167 2-amino-5-nitrothiazole Drugs 0.000 claims description 4
- WNLMYNASWOULQY-UHFFFAOYSA-N 4-tert-butylbenzoyl chloride Chemical compound CC(C)(C)C1=CC=C(C(Cl)=O)C=C1 WNLMYNASWOULQY-UHFFFAOYSA-N 0.000 claims description 4
- XFDCNXIWKCIBAE-UHFFFAOYSA-N 5-bromo-1,3-thiazol-2-amine;hydrochloride Chemical compound Cl.NC1=NC=C(Br)S1 XFDCNXIWKCIBAE-UHFFFAOYSA-N 0.000 claims description 4
- VZEBSJIOUMDNLY-UHFFFAOYSA-N 6-bromo-1,3-benzothiazol-2-amine Chemical compound C1=C(Br)C=C2SC(N)=NC2=C1 VZEBSJIOUMDNLY-UHFFFAOYSA-N 0.000 claims description 4
- CJLUXPZQUXVJNF-UHFFFAOYSA-N 6-fluoro-1,3-benzothiazol-2-amine Chemical compound C1=C(F)C=C2SC(N)=NC2=C1 CJLUXPZQUXVJNF-UHFFFAOYSA-N 0.000 claims description 4
- GPNAVOJCQIEKQF-UHFFFAOYSA-N 6-nitro-1,3-benzothiazol-2-amine Chemical compound C1=C([N+]([O-])=O)C=C2SC(N)=NC2=C1 GPNAVOJCQIEKQF-UHFFFAOYSA-N 0.000 claims description 4
- LXYYKOIRGRAWAA-UHFFFAOYSA-N C(C)(=O)Cl.CC1=CC=C(C=C1)C Chemical compound C(C)(=O)Cl.CC1=CC=C(C=C1)C LXYYKOIRGRAWAA-UHFFFAOYSA-N 0.000 claims description 4
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 claims description 4
- XNLBCXGRQWUJLU-UHFFFAOYSA-N naphthalene-2-carbonyl chloride Chemical compound C1=CC=CC2=CC(C(=O)Cl)=CC=C21 XNLBCXGRQWUJLU-UHFFFAOYSA-N 0.000 claims description 4
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 125000001246 bromo group Chemical group Br* 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 125000001072 heteroaryl group Chemical group 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 238000002604 ultrasonography Methods 0.000 claims description 2
- 239000012346 acetyl chloride Substances 0.000 claims 1
- QIQITDHWZYEEPA-UHFFFAOYSA-N thiophene-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=CS1 QIQITDHWZYEEPA-UHFFFAOYSA-N 0.000 claims 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 abstract description 5
- 239000000758 substrate Substances 0.000 abstract description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 48
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 24
- 239000003208 petroleum Substances 0.000 description 24
- 238000005406 washing Methods 0.000 description 24
- 238000001914 filtration Methods 0.000 description 23
- 238000004821 distillation Methods 0.000 description 18
- 238000004440 column chromatography Methods 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 14
- 238000000746 purification Methods 0.000 description 12
- 238000003756 stirring Methods 0.000 description 11
- 238000003818 flash chromatography Methods 0.000 description 9
- AJYXPNIENRLELY-UHFFFAOYSA-N 2-thiophen-2-ylacetyl chloride Chemical compound ClC(=O)CC1=CC=CS1 AJYXPNIENRLELY-UHFFFAOYSA-N 0.000 description 5
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- HYBCFWFWKXJYFT-UHFFFAOYSA-N 1,3-benzothiazole-2,6-diamine Chemical class C1=C(N)C=C2SC(N)=NC2=C1 HYBCFWFWKXJYFT-UHFFFAOYSA-N 0.000 description 1
- ODIUNTQOXRXOIV-UHFFFAOYSA-N 1-[6-[[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl]-1,3-benzothiazol-2-yl]-3-(2-morpholin-4-ylethyl)urea Chemical compound C1=CC(F)=CC=C1C1=NN2C(SC=3C=C4SC(NC(=O)NCCN5CCOCC5)=NC4=CC=3)=NN=C2C=C1 ODIUNTQOXRXOIV-UHFFFAOYSA-N 0.000 description 1
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol Chemical compound C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 description 1
- UKRQMDIFLKHCRO-UHFFFAOYSA-N 2,4,6-trimethylbenzoyl chloride Chemical compound CC1=CC(C)=C(C(Cl)=O)C(C)=C1 UKRQMDIFLKHCRO-UHFFFAOYSA-N 0.000 description 1
- VGNRGOGIWXMVLI-UHFFFAOYSA-N 3-(4-chlorophenyl)propanoyl chloride Chemical compound ClC(=O)CCC1=CC=C(Cl)C=C1 VGNRGOGIWXMVLI-UHFFFAOYSA-N 0.000 description 1
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 description 1
- SKDHHIUENRGTHK-UHFFFAOYSA-N 4-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=C(C(Cl)=O)C=C1 SKDHHIUENRGTHK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
- ZBNZXTGUTAYRHI-UHFFFAOYSA-N Dasatinib Chemical compound C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1Cl ZBNZXTGUTAYRHI-UHFFFAOYSA-N 0.000 description 1
- 239000002067 L01XE06 - Dasatinib Substances 0.000 description 1
- 229940125895 MET kinase inhibitor Drugs 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960002448 dasatinib Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 208000010710 hepatitis C virus infection Diseases 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/58—Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention provides a preparation method of a (benzo) thiazole-containing amide compound, and belongs to the technical field of amide compound preparation. The invention mixes the substituted acyl chloride, the compound 1 or the compound 2, the samarium powder and the alkali in a solvent, and reacts under the ultrasonic condition to obtain the (benzo) thiazole amide compound. The samarium powder and alkali are added in the preparation of the (benzo) thiazole amide compound, and the target product is successfully synthesized by an ultrasonic-assisted method, so that the preparation method has the advantages of simplicity in operation, low cost, high product yield, wide substrate application range and the like.
Description
Technical Field
The invention relates to the technical field of amide compound preparation, in particular to a preparation method of a (benzo) thiazole-containing amide compound.
Background
Amide compounds are widely used in a variety of products with practical applications, ranging from drugs, peptides (proteins) to synthetic polymers etc. [ see: hummphrey, j.m.; chamberlin, A.R. chem. Rev.1997,97,2243-2266.]. In the field of organic synthesis, amide bonds generally play a critical role in the preparation of other compounds such as nitriles, amines, heterocycles and amino acids.
An important class of amide compounds are compounds containing (benzo) thiazole building blocks in the molecule, which often exhibit different pharmacological and physiological activities, for example: the following compound I (SAR 125844) is a highly selective MET kinase inhibitor; benzothiazole-2, 6-diamine derivative II is an antibacterial agent; compound III showed good tumor growth inhibition against multiple tumors with different genetic backgrounds (U-87 MG, a549 and HCT116 cell lines); the picomolar inhibitors of Src and Bcr-Abl kinase dasatinib (compound IV) have been used clinically; amide V containing thiazole structural units of the formula is useful for treating hepatitis C virus infection; while another thiazole ring-containing amide VI is reported to have excellent moderate metabolic stability and plasma stability.
The prior art for preparing the (benzo) thiazole amide compound has complex process and low yield. Therefore, it is important to develop a process for producing (benzo) thiazole amide-containing compounds, which can improve the yield of the (benzo) thiazole amide-containing compounds.
Disclosure of Invention
The invention aims to provide a preparation method of a (benzo) thiazole-containing amide compound, which aims to solve the problem of low yield of the (benzo) thiazole-containing amide compound in the prior art.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides a preparation method of a (benzo) thiazole amide compound, which comprises the following steps: mixing substituted acyl chloride, a compound 1 or a compound 2, samarium powder and alkali in a solvent, and reacting under ultrasonic to obtain a (benzo) thiazole amide compound;
the structural formula of the substituted acyl chloride isWherein R is 1 Is benzyl, alkyl, aryl or heteroaryl;
the structural formula of the compound 1 isWherein R is 2 And R is 3 Independently chlorine, bromine, nitro, methoxy, methyl or hydrogen; the structural formula of the compound 2 is +.>Wherein R is 4 And R is 5 Independently methyl, bromo or nitro.
Preferably, the substituted acyl chloride is phenylacetyl chloride, 2, 5-dimethylbenzylacetyl chloride, 4-chlorobenzylacetyl chloride, 4-methoxyphenylacetyl chloride, thiopheneacetyl chloride, benzoyl chloride, 2-naphthoyl chloride, 4-tert-butylbenzoyl chloride, furoyl chloride, 2-thiophenecarboxyl chloride or propionyl chloride.
Preferably, the compound 1 is 2-aminothiazole, 2-amino-5-methylthiazole, 2-amino-4-methylthiazole, 2-amino-5-nitrothiazole or 2-amino-5-bromothiazole.
Preferably, the compound 2 is 2-amino-6-chlorobenzothiazole, 2-aminobenzothiazole, 2-amino-6-fluorobenzothiazole, 2-amino-6-bromobenzothiazole, 2-amino-6-nitrobenzothiazole, 2-amino-6-methoxybenzothiazole, 2-amino-6-methylbenzothiazole or 2-amino-4-methylbenzothiazole.
Preferably, the base comprises one or more of triethylamine, pyridine, potassium hydroxide, sodium carbonate and potassium carbonate.
Preferably, the solvent comprises one or more of tetrahydrofuran, ethanol, acetonitrile, 1, 4-dioxane, ethyl acetate, dichloromethane, N-dimethylformamide and dimethyl sulfoxide.
Preferably, the molar volume ratio of the substituted acyl chloride, the compound 1 or the compound 2, the samarium powder, the alkali and the solvent is 0.4-0.8 mmol:0.4 to 0.8mmol:0.04 to 0.48mmol:0.4 to 0.8mmol: 1-8 mL.
Preferably, the frequency of the ultrasonic wave is 40-50 kHz.
Preferably, the reaction temperature is 0 to 40 ℃ and the reaction time is 15 to 600s.
The invention has the beneficial effects that:
(1) The invention adds samarium powder and alkali when preparing (benzo) thiazole amide compound, and then successfully synthesizes the target product by an ultrasonic auxiliary method.
(2) The invention has the advantages of simple operation, low cost, high product yield, wide substrate application range and the like.
Detailed Description
The invention provides a preparation method of a (benzo) thiazole amide compound, which comprises the following steps: mixing substituted acyl chloride, a compound 1 or a compound 2, samarium powder and alkali in a solvent, and reacting under ultrasonic to obtain a (benzo) thiazole amide compound;
the structural formula of the substituted acyl chloride isWherein R is 1 Is benzyl, alkyl, aryl or heteroaryl;
the structural formula of the compound 1 isWherein R is 2 And R is 3 Independently chlorine, bromine, nitro, methoxy, methyl or hydrogen; the structural formula of the compound 2 is +.>Wherein R is 4 And R is 5 Independently methyl, bromo or nitro.
In the present invention, the substituted acyl chloride is phenylacetyl chloride, 2, 5-dimethylbenzene acetyl chloride, 4-chlorobenzoyl chloride, 4-methoxyphenylacetyl chloride, thiopheneacetyl chloride, benzoyl chloride, 2-naphthoyl chloride, 4-t-butylbenzoyl chloride, furoyl chloride, 2-thiophenoyl chloride or propionyl chloride, preferably phenylacetyl chloride, 2, 5-dimethylbenzene acetyl chloride, 4-chlorobenzoyl acetyl chloride, 4-methoxyphenylacetyl chloride, thiopheneacetyl chloride, furoyl chloride or propionyl chloride, further preferably phenylacetyl chloride, 4-chlorobenzoyl chloride, 4-methoxyphenylacetyl chloride, thiopheneacetyl chloride or propionyl chloride.
In the present invention, the compound 1 is 2-aminothiazole, 2-amino-5-methylthiazole, 2-amino-4-methylthiazole, 2-amino-5-nitrothiazole or 2-amino-5-bromothiazole, preferably 2-aminothiazole, 2-amino-5-methylthiazole or 2-amino-4-methylthiazole, more preferably 2-aminothiazole or 2-amino-5-methylthiazole.
In the present invention, the compound 2 is 2-amino-6-chlorobenzothiazole, 2-aminobenzothiazole, 2-amino-6-fluorobenzothiazole, 2-amino-6-bromobenzothiazole, 2-amino-6-nitrobenzothiazole, 2-amino-6-methoxybenzothiazole, 2-amino-6-methylbenzothiazole or 2-amino-4-methylbenzothiazole, preferably 2-amino-6-chlorobenzothiazole, 2-aminobenzothiazole, 2-amino-6-methoxybenzothiazole, 2-amino-6-methylbenzothiazole or 2-amino-4-methylbenzothiazole, more preferably 2-amino-6-methoxybenzothiazole, 2-amino-6-methylbenzothiazole or 2-amino-4-methylbenzothiazole.
In the present invention, the base contains one or more of triethylamine, pyridine, potassium hydroxide, sodium carbonate and potassium carbonate, preferably one or more of pyridine, potassium hydroxide and sodium carbonate, and more preferably pyridine and/or potassium hydroxide.
In the present invention, the solvent contains one or more of tetrahydrofuran, ethanol, acetonitrile, 1, 4-dioxane, ethyl acetate, dichloromethane, N-dimethylformamide and dimethylsulfoxide, preferably one or more of tetrahydrofuran, ethanol, acetonitrile, 1, 4-dioxane, ethyl acetate and dichloromethane, more preferably one or more of tetrahydrofuran, ethanol, acetonitrile and 1, 4-dioxane.
In the invention, the molar volume ratio of the substituted acyl chloride, the compound 1 or the compound 2, the samarium powder, the alkali and the solvent is 0.4-0.8 mmol:0.4 to 0.8mmol: :0.04 to 0.48mmol:0.4 to 0.8mmol:1 to 8mL, preferably 0.5 to 0.7mmol:0.5 to 0.7mmol:0.10 to 0.45mmol:0.5 to 0.7mmol:2 to 7mL, more preferably 0.55 to 0.65mmol:0.55 to 0.65mmol:0.15 to 0.40mmol:0.55 to 0.65mmol: 3-6 mL.
In the present invention, the ultrasonic frequency is 40 to 50kHz, preferably 42 to 48kHz, and more preferably 45kHz.
In the present invention, the temperature of the reaction is 0 to 40 ℃, preferably 5 to 35 ℃, and more preferably 10 to 20 ℃; the time is 15 to 600 seconds, preferably 30 to 550 seconds, and more preferably 50 to 500 seconds.
The technical solutions provided by the present invention are described in detail below with reference to examples, but they should not be construed as limiting the scope of the present invention.
Example 1
Mixing 0.5mmol of phenylacetyl chloride, 0.5mmol of 2-amino-6-chlorobenzothiazole, 0.25mmol of samarium powder and 0.5mmol of pyridine in 4mL of tetrahydrofuran, reacting for 60s at 0 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, and purifying by flash column chromatography with petroleum ether as a mobile phase to obtain a pure product 3a, wherein the structural formula isThe yield was 94%.
1 H NMR(400MHz,d 6 -DMSO)δ3.85(s,2H),7.27–7.30(m,1H),7.35(d,J=4.4Hz,4H),7.46(dd,J=8.6,2.2Hz,1H),7.75(d,J=8.7Hz,1H),8.12(d,J=2.1Hz,1H),12.70(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ42.3,121.9,122.2,126.9,127.4,128.1,128.9,129.8,133.6,135.0,147.8,159.2,170.9.
Example 2
0.4mmol of phenylacetyl chloride, 0.4mmol of 2-aminobenzothiazole, 0.2mmol of samarium powder and 0.4mmol of pyridine are mixed in 5mL of dichloromethane, reacted for 100s at 25 ℃ under the ultrasonic wave with the frequency of 40kHz, and then cisFiltering with diatomite, washing with ethyl acetate, distilling under reduced pressure to remove solvent, and purifying with flash column chromatography with ethyl acetate and petroleum ether as mobile phase to obtain pure product 3b with structural formula ofThe yield was 95%.
1 H NMR(400MHz,d 6 -DMSO)δ3.86(s,2H),7.25–7.31(m,2H),7.32–7.38(m,4H),7.41–7.46(m,1H),7.75(d,J=7.9Hz,1H),7.96(d,J=7.9Hz,1H),12.63(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ42.3,120.9,122.2,124.0,126.6,127.4,128.9,129.8,131.9,135.2,148.9,158.4,170.2.
Example 3
Mixing 0.6mmol of phenylacetyl chloride, 0.6mmol of 2-amino-6-fluorobenzothiazole, 0.3mmol of samarium powder and 0.6mmol of triethylamine in 8mL of ethanol, reacting for 200s at 40 ℃ under the ultrasonic wave with the frequency of 50kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, purifying by flash column chromatography by taking ethyl acetate and petroleum ether as mobile phases to obtain a pure product, namely 3c, with the structural formula ofThe yield was 88%.
1 H NMR(400MHz,d 6 -DMSO)δ3.84(s,2H),7.27–7.32(m,3H),7.35(d,J=4.5Hz,3H),7.76(dd,J=8.9,4.8Hz,1H),7.89(dd,J=8.7,2.6Hz,1H),12.64(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ42.3,108.6(d,J CF =26.9Hz),114.7(d,J CF =24.4Hz),122.1(d,J CF =9.1Hz),127.0,127.4,128.9,129.8,133.2(d,J CF =11.1Hz),135.1,145.7,159.1(d,J CF =239.9Hz),170.8.
Example 4
Mixing 0.8mmol of phenylacetyl chloride, 0.8mmol of 2-amino-6-bromobenzothiazole, 0.48mmol of samarium powder and 0.8mmol of sodium carbonate in 7mL of ethyl acetate, reacting for 400s at 0 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, and steaming under reduced pressureDistilling to remove solvent, ethyl acetate and petroleum ether as mobile phase, and performing rapid column chromatography purification to obtain pure product 3d with structural formula ofThe yield was 92%.
1 H NMR(400MHz,d 6 -DMSO)δ3.85(s,2H),7.26–7.30(m,1H),7.35(d,J=4.5Hz,4H),7.58(dd,J=8.6,2.1Hz,1H),7.69(d,J=8.6Hz,1H),8.25(d,J=1.9Hz,1H),12.71(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ42.3,115.9,122.6,124.8,127.4,128.9,129.6,129.8,134.1,135.0,148.2,159.2,170.9.HRMS(ESI)m/z:calcd for C 15 H 11 BrN 2 OS(M+H) + 346.9848,found 346.9845.
Example 5
Mixing 0.8mmol of phenylacetyl chloride, 0.8mmol of 2-amino-6-nitrobenzothiazole, 0.15mmol of samarium powder and 0.8mmol of potassium carbonate into 6mL of dimethyl sulfoxide, reacting for 100s at 25 ℃ under 50kHz ultrasonic, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, purifying by flash column chromatography by taking petroleum ether as a mobile phase to obtain a pure product, namely 3e, with the structural formula ofThe yield thereof was found to be 82%.
1 H NMR(400MHz,d 6 -DMSO)δ3.90(s,2H),7.27–7.38(m,5H),7.91(d,J=9.0Hz,1H),8.29(dd,J=8.9,2.4Hz,1H),9.06(d,J=2.4Hz,1H),13.03(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ42.3,119.5,121.1,122.2,127.5,128.9,129.9,132.7,134.8,143.5,153.9,163.9,171.4.
Example 6
Mixing 0.5mmol of phenylacetyl chloride, 0.5mmol of 2-amino-6-methoxybenzothiazole, 0.30mmol of samarium powder and 0.5mmol of pyridine in 3mL of N, N-dimethylformamide, reacting for 80s at 40 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing the solvent by reduced pressure distillation, ethyl acetate and petroleum ether as the componentsPurifying the mobile phase by rapid column chromatography to obtain pure product 3f with structural formula ofThe yield thereof was found to be 97%.
1 H NMR(400MHz,d 6 -DMSO)δ3.56(s,3H),3.81(s,2H),7.02(dd,J=8.8,2.5Hz,1H),7.24–7.35(m,5H),7.55(d,J=2.4Hz,1H),7.64(d,J=8.8Hz,1H),12.45(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ42173.2.3,56.1,105.2,115.4,121.6,127.3,128.7,129.8,133.2,135.5,143.1,156.2,170.4.
Example 7
Mixing 0.7mmol of phenylacetyl chloride, 0.7mmol of 2-amino-6-methylbenzothiazole, 0.25mmol of samarium powder and 0.7mmol of potassium hydroxide in 5mL of 1, 4-dioxane, reacting for 360s at 0 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, distilling under reduced pressure to remove solvent, ethyl acetate and petroleum ether as mobile phase, and performing rapid column chromatography purification to obtain a pure product, 3g, with the structural formula ofThe yield was 94%.
1 H NMR(400MHz,d 6 -DMSO)δ2.41(s,3H),3.82(s,2H),7.24–7.36(m,6H),7.63(d,J=8.2Hz,1H),7.75(s,1H),12.53(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ21.4,42.3,120.6,121.8,127.3,127.9,128.9,129.8,132.0,133.5,135.2,146.9,157.5,170.5.HRMS(ESI)m/z:calcd for C 16 H 14 N 2 OS(M+H) + 283.0900,found 283.0906.
Example 8
Mixing 0.7mmol of phenylacetyl chloride, 0.7mmol of 2-amino-4-methylbenzothiazole, 0.45mmol of samarium powder and 0.7mmol of triethylamine in 8mL of tetrahydrofuran, reacting for 500s at 25 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing the solvent by reduced pressure distillation, purifying by flash column chromatography by taking ethyl acetate and petroleum ether as mobile phases to obtain a pure product, wherein the pure product is 3h in structureIs of the typeThe yield was 90%.
1 H NMR(400MHz,d 6 -DMSO)δ2.58(s,3H),3.83(s,2H),7.20(t,J=7.6Hz,1H),7.25–7.30(m,2H),7.35–7.38(m,4H),7.78(d,J=7.8Hz,1H),12.69(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ18.4,42.3,119.6,123.9,127.1,127.4,128.9,129.8,130.3,131.6,135.2,148.1,157.5,170.6.HRMS(ESI)m/z:calcd for C 16 H 14 N 2 OS(M+H) + 283.0900,found 283.0896.
Example 9
Mixing 0.5mmol of phenylacetyl chloride, 0.5mmol of 2-aminothiazole, 0.15mmol of samarium powder and 0.5mmol of triethylamine in 6mL of ethanol, reacting for 600s at 40 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, and performing rapid column chromatography purification by taking ethyl acetate and petroleum ether as mobile phases to obtain a pure product 3i with the structural formula ofThe yield was 95%.
1 H NMR(400MHz,d 6 -DMSO)δ3.77(s,2H),7.20(d,J=3.6Hz,1H),7.25–7.34(m,5H),7.47(d,J=3.6Hz,1H),12.35(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ42.1,113.9,127.3,128.9,129.7,135.5,138.1,158.4,169.6.
Example 10
Mixing 0.6mmol of phenylacetyl chloride, 0.6mmol of 2-amino-5-methylthiazole, 0.15mmol of samarium powder and 0.6mmol of pyridine in 8mL of tetrahydrofuran, reacting for 300s at 25 ℃ under the ultrasonic with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, and purifying by flash column chromatography with petroleum ether as a mobile phase to obtain a pure product 3j with the structural formula ofThe yield was 96%.
1 H NMR(400MHz,d 6 -DMSO)δ2.32(s,3H),3.73(s,2H),7.13(s,1H),7.24–7.35(m,5H),12.14(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ11.5,42.1,126.6,127.2,128.9,129.7,135.2,135.6,156.6,169.3.
Example 11
Mixing 0.6mmol of phenylacetyl chloride, 0.6mmol of 2-amino-4-methylthiazole, 0.25mmol of samarium powder and 0.6mmol of triethylamine in 5mL of ethanol, reacting for 500s at 40 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, and purifying by flash column chromatography with petroleum ether as a mobile phase to obtain a pure product 3k with the structural formula ofThe yield was 92%.
1 H NMR(400MHz,d 6 -DMSO)δ2.26(s,3H),3.73(s,2H),6.74(s,1H),7.24–7.33(m,5H),12.27(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ17.3,42.2,108.1,127.3,128.9,129.7,135.5,147.1,157.7,169.5.
Example 12
Mixing 0.5mmol of phenylacetyl chloride, 0.5mmol of 2-amino-5-nitrothiazole, 0.15mmol of samarium powder and 0.5mmol of potassium carbonate in 7mL of acetonitrile, reacting for 200s at 0 ℃ under the ultrasonic wave with the frequency of 40kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, and purifying by flash column chromatography with petroleum ether as a mobile phase to obtain a pure product 3l, wherein the structural formula isThe yield was 69%.
1 H NMR(400MHz,d 6 -DMSO)δ3.88(s,2H),7.22–7.35(m,5H),8.63(s,1H),12.29(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ41.9,127.5,128.7,129.8,134.5,135.5,143.1,162.2,171.6.
Example 13
0.8mmol of phenylacetyl chloride,Mixing 0.8mmol of 2-amino-5-bromothiazole, 0.45mmol of samarium powder and 0.8mmol of potassium hydroxide in 7mL of ethyl acetate, reacting for 450s at 25 ℃ under the ultrasonic with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing the solvent by reduced pressure distillation, purifying by flash column chromatography with ethyl acetate and petroleum ether as mobile phases to obtain a pure product 3m, wherein the structural formula isThe yield was 91%.
1 H NMR(400MHz,d 6 -DMSO)δ3.78(s,2H),7.25–7.35(m,5H),7.56(s,1H),12.62(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ41.8,102.1,127.4,128.9,129.7,135.1,139.2,158.8,170.2.
Example 14
Mixing 0.4mmol of 2, 5-dimethylbenzene acetyl chloride, 0.4mmol of 2-aminothiazole, 0.35mmol of samarium powder and 0.4mmol of potassium hydroxide in 3mL of ethanol, reacting for 500s at 40 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, removing ethyl acetate and petroleum ether as mobile phases in sequence, and performing rapid column chromatography purification to obtain a pure product, namely a product 4a, with the structural formula ofThe yield was 89%.
1 H NMR(400MHz,d 6 -DMSO)δ2.22(s,3H),2.24(s,3H),3.76(s,2H),6.97(d,J=7.7Hz,1H),7.05(d,J=3.9Hz,2H),7.19(d,J=3.5Hz,1H),7.47(d,J=3.5Hz,1H),12.31(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ19.3,20.9,39.8,113.9,127.9,130.4,131.2,133.9,134.0,135.1,138.1,158.5,169.6.HRMS(ESI)m/z:calcd for C 13 H 14 N 2 OS(M+H) + 247.0900,found 247.0892.
Example 15
Mixing 0.6mmol of 4-chlorobenzoyl acetyl chloride, 0.6mmol of 2-aminothiazole, 0.35mmol of samarium powder and 0.6mmol of potassium hydroxide in 5mL of tetrahydrofuran, and reacting for 550s at 0 ℃ under the ultrasonic wave with the frequency of 45kHzThen sequentially filtering with diatomite, washing with ethyl acetate, distilling under reduced pressure to remove solvent, and performing rapid column chromatography purification with ethyl acetate and petroleum ether as mobile phases to obtain pure product 4b with structural formula ofThe yield was 96%.
1 H NMR(400MHz,d 6 -DMSO)δ3.78(s,2H),7.20(d,J=3.5Hz,1H),7.35(d,J=8.4Hz,2H),7.40(d,J=8.4Hz,2H),7.47(d,J=3.5Hz,1H),12.35(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ41.3,114.0,128.8,131.6,132.0,134.4,138.1,158.4,169.3.
Example 16
Mixing 0.8mmol of 4-methoxy phenylacetyl chloride, 0.8mmol of 2-aminothiazole, 0.45mmol of samarium powder and 0.8mmol of pyridine in 8mL of dichloromethane, reacting for 300s at 40 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, removing ethyl acetate and petroleum ether as mobile phase, and performing rapid column chromatography purification to obtain a pure product, namely 4c, with the structural formula ofThe yield was 95%.
1 H NMR(400MHz,d 6 -DMSO)δ3.68(s,2H),3.73(s,3H),6.89(d,J=8.5Hz,2H),7.19(d,J=3.5Hz,1H),7.24(d,J=8.5Hz,2H),7.46(d,J=3.5Hz,1H),12.27(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ41.2,55.5,113.9,114.3,127.4,130.7,138.1,158.5,158.7,169.9.
Example 17
Mixing 0.4mmol of thiophene acetyl chloride, 0.4mmol of 2-aminothiazole, 0.15mmol of samarium powder and 0.4mmol of sodium carbonate into 5mL of N, N-dimethylformamide, reacting for 150s at 25 ℃ under the ultrasonic with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing the solvent by reduced pressure distillation, purifying by using ethyl acetate and petroleum ether as a mobile phase, and performing rapid column chromatography to obtain a pure product, namely a product 4d, with the structural formula ofThe yield was 92%.
1 H NMR(400MHz,d 6 -DMSO)δ4.00(s,2H),6.97–6.99(m,2H),7.22(d,J=3.5Hz,1H),7.41(dd,J=4.8,1.1Hz,1H),7.48(d,J=3.5Hz,1H),12.35(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ36.4,114.1,125.9,127.2,127.3,136.4,138.2,158.4,168.6.HRMS(ESI)m/z:calcd for C 9 H 8 N 2 OS 2 (M+H) + 225.0151,found 225.0150.
Example 18
Mixing 0.7mmol of benzoyl chloride, 0.7mmol of 2-aminothiazole, 0.45mmol of samarium powder and 0.7mmol of triethylamine in 5mL of dimethyl sulfoxide, reacting for 350s at 0 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, and performing rapid column chromatography purification by taking ethyl acetate and petroleum ether as mobile phases to obtain a pure product 4e with the structural formula ofThe yield was 88%.
1 H NMR(400MHz,d 6 -DMSO)δ7.29(d,J=3.5Hz,1H),7.48–7.57(m,3H),7.64(t,J=7.3Hz,1H),8.10(d,J=7.9Hz,2H),12.65(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ114.3,128.6,129.0,132.7,132.9,138.1,159.2,165.6.
Example 19
Mixing 0.6mmol of 2-naphthoyl chloride, 0.6mmol of 2-aminothiazole, 0.25mmol of samarium powder and 0.6mmol of potassium hydroxide in 6mL of ethanol, reacting for 180s at 25 ℃ under the ultrasonic with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, removing ethyl acetate and petroleum ether as mobile phases in sequence, and performing rapid column chromatography purification to obtain a pure product, namely 4f, with the structural formula ofThe yield was 79%.
1 H NMR(400MHz,d 6 -DMSO)δ7.31(d,J=3.5Hz,1H),7.59(d,J=3.5Hz,1H),7.62–7.70(m,2H),8.01–8.09(m,3H),8.13(d,J=8.6Hz,1H),8.79(s,1H),12.77(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ114.3,124.8,127.5,128.2,128.7,128.8,129.6,129.7,129.9,132.5,135.1,138.1,159.3,165.7.HRMS(ESI)m/z:calcd for C 14 H 10 N 2 OS(M+H) + 255.0587,found 255.0591.
Example 20
Mixing 0.7mmol of 4-tert-butylbenzoyl chloride, 0.7mmol of 2-aminothiazole, 0.35mmol of samarium powder and 0.7mmol of potassium hydroxide in 7mL of 1, 4-dioxane, reacting for 260s at 40 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, distilling under reduced pressure to remove the solvent, removing the ethyl acetate and petroleum ether as a mobile phase, and purifying by rapid column chromatography to obtain a pure product, 4g, with the structural formula ofThe yield was 86%.
1 H NMR(400MHz,d 6 -DMSO)δ1.32(s,9H),7.28(d,J=3.6Hz,1H),7.56(dd,J=6.0,2.3Hz,3H),8.05(d,J=8.3Hz,2H),12.56(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ31.3,35.2,114.2,125.9,128.5,129.8,138.1,155.9,159.2,165.3.
Example 21
Mixing 0.8mmol of furoyl chloride, 0.8mmol of 2-aminothiazole, 0.35mmol of samarium powder and 0.8mmol of potassium hydroxide in 8mL of dichloromethane, reacting for 430s at 25 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, removing ethyl acetate and petroleum ether as mobile phases, and performing rapid column chromatography purification to obtain a pure product, wherein the pure product is obtained for 4h and has the structural formula ofThe yield was 89%.
1 H NMR(400MHz,d 6 -DMSO)δ6.73–6.75(m,1H),7.27(d,J=3.5Hz,1H),7.55(d,J=3.6Hz,1H),7.65(d,J=3.5Hz,1H),8.01(s,1H),12.59(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ112.7,114.3,116.8,137.9,146.2,147.6,156.4,158.6.
Example 22
Mixing 0.8mmol of 2-thiophenecarboxchloride, 0.8mmol of 2-aminothiazole, 0.48mmol of samarium powder and 0.8mmol of potassium hydroxide in 8mL of tetrahydrofuran, reacting for 600s at 40 ℃ under the ultrasonic wave with the frequency of 45kHz, then sequentially filtering with diatomite, washing with ethyl acetate, distilling under reduced pressure to remove the solvent, ethyl acetate and petroleum ether as mobile phases, and carrying out rapid column chromatography purification to obtain a pure product, namely 4i, with the structural formula ofThe yield was 87%.
1 H NMR(400MHz,d 6 -DMSO)δ7.24–7.28(m,2H),7.56(d,J=3.6Hz,1H),7.96(d,J=4.9Hz,1H),8.24(d,J=3.0Hz,1H),12.74(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ114.3,129.0,131.2,133.9,137.7,137.9,159.2,160.3.
Example 23
Mixing 0.6mmol of propionyl chloride, 0.6mmol of 2-aminothiazole, 0.24mmol of samarium powder and 0.6mmol of pyridine in 5mL of tetrahydrofuran, reacting for 340s at 28 ℃ under the ultrasonic wave with the frequency of 45kHz, filtering by diatomite, washing by ethyl acetate, removing solvent by reduced pressure distillation, and performing rapid column chromatography purification by taking ethyl acetate and petroleum ether as mobile phases to obtain a pure product 4j, wherein the structural formula isThe yield thereof was found to be 97%.
1 H NMR(400MHz,d 6 -DMSO)δ1.09(t,J=7.5Hz,3H),2.44(q,J=7.5Hz,2H),7.16–7.18(m,1H),7.45(d,J=3.5Hz,1H),12.03(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ9.6,28.6,113.6,137.9,158.6,172.4.
Example 24
20mmol of 4-chlorobenzoyl acetyl chloride, 20mmol of 2-aminothiazole, 10mmol of samarium powder and 20mmol of pyridine are mixed in 60mL of dichloromethane, reacted for 180s at 25 ℃ under the ultrasonic wave with the frequency of 40kHz, and then the pure product is obtained by rapid column chromatography purification by taking diatomite for filtration, ethyl acetate for washing, reduced pressure distillation to remove the solvent, ethyl acetate and petroleum ether as mobile phases, wherein the yield is 92%.
1 H NMR(400MHz,d 6 -DMSO)δ3.78(s,2H),7.20(d,J=3.5Hz,1H),7.35(d,J=8.4Hz,2H),7.40(d,J=8.4Hz,2H),7.47(d,J=3.5Hz,1H),12.35(s,1H); 13 C NMR(100MHz,d 6 -DMSO)δ41.3,114.0,128.8,131.6,132.0,134.4,138.1,158.4,169.3.
Comparative example 1
The difference from example 1 is that no base was added and the reaction was carried out at 25℃for 1.5h under stirring, all other conditions being identical, the product obtained was 3a in 45% yield.
Comparative example 2
The difference from example 1 is that the base added is triethylamine and the reaction is carried out for 1.5h at 25℃with stirring, all other conditions being identical, the product obtained being 3a in 73% yield.
Comparative example 3
The difference from example 1 is that the reaction is carried out for 1.5h at 25℃with stirring, the other conditions being identical, the product obtained being 3a in 86% yield.
Comparative example 4
The difference from example 1 is that the base added is potassium hydroxide and reacted at 25℃for 1.5h with stirring, all other conditions being identical, the product obtained is 3a in 65% yield.
Comparative example 5
The difference from example 1 is that the base added is sodium carbonate and the reaction is carried out for 1.5h at 25℃with stirring, the other conditions being the same, the product obtained being 3a with a yield of 82%.
Comparative example 6
The difference from example 1 is that the base added is potassium carbonate and the reaction is carried out for 1.5h at 25℃with stirring, all other conditions being identical, the product obtained is 3a with a yield of 62%.
Comparative example 7
The difference from example 1 is that the added base is sodium hydroxide and the reaction is carried out for 1.5h at 25℃with stirring, the other conditions being the same, the product obtained being 3a with a yield of 67%.
Comparative example 8
The difference from example 1 is that the samarium powder was used in an amount of 0.15mmol, and reacted at 25℃for 1.5 hours under stirring under the same conditions, to give a product of 3a in 79% yield.
Comparative example 9
The difference from example 1 is that the samarium powder was used in an amount of 0.05mmol, and reacted at 25℃for 1.5 hours under stirring under the same conditions, to give a product of 3a in a yield of 68%.
Comparative example 10
The difference from example 1 was that samarium powder was not added, and the reaction was carried out at 25℃for 1.5 hours under stirring under the same conditions, to obtain 3a as a product in 52% yield.
Comparative example 11
The difference from example 1 was that the samarium powder was used in an amount of 0.3mmol, and reacted at 25℃for 1.5 hours under stirring under the same conditions, to give a product of 3a in a yield of 87%.
By comparing example 1 with the comparative example, it can be found that the addition amount of samarium powder and different kinds of alkali affect the yield of the product, and the highest yield of the product can be ensured under the combined action of ultrasonic conditions and samarium powder.
Comparative example 12
The difference from example 14 is that 4-nitrobenzoyl chloride is reacted with 2-aminothiazole under the same conditions, and the corresponding amide compound is not obtained.
Comparative example 13
The difference from example 14 is that 2,4, 6-trimethylbenzoyl chloride is reacted with 2-aminothiazole under the same conditions, and only a trace amount of the amide compound is obtained.
From the above examples, the present invention provides a process for producing (benzo) thiazole amide compounds, which comprises mixing a substituted acyl chloride, compound 1 or compound 2, samarium powder and a base in a solvent, and reacting under ultrasound to obtain (benzo) thiazole amide compounds. The method has the advantages of simple operation, low cost, high product yield, wide substrate application range and the like in the preparation of the (benzo) thiazole amide compound.
The foregoing is merely a preferred embodiment of the present invention and it should be noted that modifications and adaptations to those skilled in the art may be made without departing from the principles of the present invention, which are intended to be comprehended within the scope of the present invention.
Claims (9)
1. A process for the preparation of a (benzo) thiazole amide containing compound comprising the steps of: mixing substituted acyl chloride, a compound 1 or a compound 2, samarium powder and alkali in a solvent, and reacting under ultrasonic to obtain a (benzo) thiazole amide compound;
the structural formula of the substituted acyl chloride isWherein R is 1 Is benzyl, alkyl, aryl or heteroaryl;
the structural formula of the compound 1 isWherein R is 2 And R is 3 Independently chlorine, bromine, nitro, methoxy, methyl or hydrogen; the structural formula of the compound 2 is +.>Wherein R is 4 And R is 5 Independently methyl, bromo or nitro.
2. The method according to claim 1, wherein the substituted acyl chloride is phenylacetyl chloride, 2, 5-dimethylbenzene acetyl chloride, 4-chlorobenzoyl chloride, 4-methoxyphenylacetyl chloride, thiophenyl acetyl chloride, benzoyl chloride, 2-naphthoyl chloride, 4-t-butylbenzoyl chloride, furoyl chloride, 2-thiophenyl formyl chloride or propionyl chloride.
3. The preparation method according to claim 1 or 2, wherein the compound 1 is 2-aminothiazole, 2-amino-5-methylthiazole, 2-amino-4-methylthiazole, 2-amino-5-nitrothiazole or 2-amino-5-bromothiazole.
4. The preparation method according to claim 1 or 2, wherein the compound 2 is 2-amino-6-chlorobenzothiazole, 2-aminobenzothiazole, 2-amino-6-fluorobenzothiazole, 2-amino-6-bromobenzothiazole, 2-amino-6-nitrobenzothiazole, 2-amino-6-methoxybenzothiazole, 2-amino-6-methylbenzothiazole or 2-amino-4-methylbenzothiazole.
5. The method according to claim 2, wherein the base comprises one or more of triethylamine, pyridine, potassium hydroxide, sodium carbonate and potassium carbonate.
6. The method according to claim 1, 2 or 5, wherein the solvent comprises one or more of tetrahydrofuran, ethanol, acetonitrile, 1, 4-dioxane, ethyl acetate, dichloromethane, N-dimethylformamide and dimethylsulfoxide.
7. The preparation method according to claim 6, wherein the molar volume ratio of the substituted acyl chloride, the compound 1 or the compound 2, the samarium powder, the base and the solvent is 0.4 to 0.8mmol:0.4 to 0.8mmol:0.04 to 0.48mmol:0.4 to 0.8mmol: 1-8 mL.
8. The method according to claim 5 or 7, wherein the frequency of the ultrasound is 40 to 50kHz.
9. The method according to claim 8, wherein the reaction is carried out at a temperature of 0 to 40 ℃ for a time of 15 to 600 seconds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311086798.1A CN117126119A (en) | 2023-08-28 | 2023-08-28 | Preparation method of (benzo) thiazole amide-containing compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311086798.1A CN117126119A (en) | 2023-08-28 | 2023-08-28 | Preparation method of (benzo) thiazole amide-containing compound |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117126119A true CN117126119A (en) | 2023-11-28 |
Family
ID=88855924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311086798.1A Pending CN117126119A (en) | 2023-08-28 | 2023-08-28 | Preparation method of (benzo) thiazole amide-containing compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117126119A (en) |
-
2023
- 2023-08-28 CN CN202311086798.1A patent/CN117126119A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3752488B1 (en) | Method for preparing tert-butyl n-((1r,2s,5s)-2-((2-((5-chloropyridin-2-yl)amino)-2-oxoacetyl)amino)-5-(dimethylcarbamoyl)cyclohexyl)carbamate | |
CN109438264B (en) | Polysubstituted indenamine derivative and preparation method thereof | |
CN113461631B (en) | 1,3, 4-oxadiazole neuraminidase inhibitor and preparation method and application thereof | |
CN108610304B (en) | Synthetic method of diaryl sultam compound | |
CN117126119A (en) | Preparation method of (benzo) thiazole amide-containing compound | |
CN113735778A (en) | Preparation method of 5-trifluoromethyl substituted imidazole compound | |
CN108997305A (en) | A kind of new compound 3- methyl -4,5- dichloro-thiophene -2- carboxylic acid and preparation method thereof | |
CN105820174B (en) | A kind of preparation method of polysubstituted thiophene diindyl derivative | |
CN112250636A (en) | 5-aminoimidazole compound and synthesis method thereof | |
CN106866563B (en) | Method for preparing 2, 4-disubstituted-1, 3,5 triazine derivative | |
CN113666826B (en) | Aryl or heteroaryl methoxylation reaction method | |
CN108191849B (en) | Preparation method of anti-epidermal growth factor receptor drug resistance mutation inhibitor, related intermediate and application | |
CN111362973B (en) | Synthetic method of 1, 2-benzothiazine derivative | |
CN108503600B (en) | Polysubstituted quinoxaline derivative and preparation method thereof | |
CN104945305A (en) | Method for achieving indole derivative selective aromatic thiolation | |
CN103664875B (en) | Isosorbide-5-Nitrae, the synthetic method of 5,6-tetrahydropyrimidinederivatives derivatives | |
JP4871273B2 (en) | 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acid, process for its preparation and use as a medicament | |
CN104610133A (en) | Method for synthesizing novel anticancer medicine entinostat | |
CN106220586B (en) | A kind of preparation method of 5- amido -1,2,4- selenium oxadiazole derivative | |
CN104016872A (en) | Synthetic method for chiral alpha-unnatural amino acid | |
CN111269155A (en) | Method for synthesizing alkenyl sulfone compound under metal-free condition | |
CN109988175A (en) | A kind of preparation method for replacing Buddhist nun-d5 according to Shandong | |
CN114230526B (en) | Synthesis method of 4-3 (H) quinazolinone and derivative thereof | |
CN108250157B (en) | Method for synthesizing N- [2- (2-arylbenzothiazole) ] -amide under catalysis of rhodium | |
CN113816949B (en) | Preparation method of arotinolol hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |